IDEXX CEO resigns following spinal cord injuryOctober 25, 2019Jonathan Ayers, president, CEO, and chair of IDEXX Laboratories, is stepping down after suffering a spinal cord injury.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started